GALT icon

Galectin Therapeutics

60 hedge funds and large institutions have $14.8M invested in Galectin Therapeutics in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$187K
Puts
$30K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.08M
2
$2.67M
3
$1.62M
4
$1.1M
5
$898K
6
$553K
7
$395K
8
$386K
9
$365K
10
$299K
11
$277K
12
$272K
13
$199K
14
$118K
15
$118K
16
$115K
17
$110K
18
$101K
19
$94.9K
20
$85.1K
21
$84.9K
22
$79.6K
23
$75.8K
24
$68.9K
25
$63.7K